The Indian hospital industry accounting for 80% of the total healthcare market is expected to touch US$ 132 billion by 2023
80 Mn
eSanjeevani telemedicine consultations
45.06%
Increase in the total investments in healthtech startups.
40%
Share in hospital beds (Pvt.)
22.9%
Industry CAGR (2015-20)
Ayushman Bharat
aims to provide annual healthcare coverage of nearly US$7,000 per family, benefiting more than 500 million vulnerable people.
33.33%
share in the total gross written premiums earned in the country
US$ 4.32 billion
M&A activity for the healthcare and pharmaceutical sector in India in the first half of 2022
INR 485.43 Bn
Valuation of digital healthcare market in India by 2024
US$ 19.41 bn
FDI inflows for the drugs and pharmaceuticals sector between April 2000-March 2022
+91-11-23379651
+91 124 4382629
+91-22-28741366
+91-11-23370009, +91-9999116375
India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive and capital establishments
American drugmaker Merck operates a manufacturing plant in India.
French drugmaker Sanofi operates a manufacturing plant in Goa.
UK's GlaxoSmithKline operates R&D and manufacturing in India.
Singapore's 4CE Ventures has invested in Indian health tech startups.
India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive, and capital establishments
India’s non-technology sector is expected to create over 1 million …
Read MoreIndia has recently signed a memorandum of understanding (MoU) with …
Read MoreThe Indian government is developing a pandemic preparedness program which …
Read More